Dermata Therapeutics, Inc. - Common Stock (DRMA)

- Kyra Peckaitis will lead the launch of Dermata's recently announced Tome skincare brand -

-The oldest new thing in skincare -

This patent grant follows the Company's U.S. issued patent, covering its Spongilla technology combination as a method to topically treat acne

Let's explore the current happenings on the US markets on Tuesday. Below, you'll find the stocks exhibiting unusual volume in today's session.

In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.

Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.

$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon the exercise in full of warrants

Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

The company has entered into definitive agreements to issue roughly 2.02 million shares of its common stock in a private placement deal.

Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon the exercise in full of warrants

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

SAN DIEGO, CA / ACCESS Newswire / December 4, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a science-driven leader in dermatologic solutions, today announced that it will soon reveal its new brand name for its over-the-counter ("OTC") skincare business representing its evolution toward a more direct, science-first era of dermatologic innovation. While the name remains confidential until the formal unveiling, the Company is offering a first look at the mission and essence driving this new identity-one created specifically for the community of skincare consumers who expect more from their products, their science, and the companies behind them.